Cangrelor Ticagrelor Transition Study

NCT01766466 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: cangrelor
DRUG: Ticagrelor

Sponsor

The Medicines Company